Fludarabine, cyclophosphamide and rituximab up to four courses as first line treatment for indolent non-hodgkin lymphomas

被引：0
|
作者：
Falantes, J. F. [1 ]
Ríos Herranz, E. [1 ]
Marin Niebla, A. [1 ]
Martino Galiana, M. L. [1 ]
Parody, R. [1 ]
Blas Orlando, J. M. [1 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1094
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas
    Fabbri, Alberto
    Cencini, Emanuele
    Rigacci, Luigi
    Bartalucci, Giulia
    Puccini, Benedetta
    Dottori, Roberto
    Gozzetti, Alessandro
    Bosi, Alberto
    Bocchia, Monica
    LEUKEMIA & LYMPHOMA, 2014, 55 (04) : 781 - 785
  • [2] Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma
    Tam, Constantine S.
    Wolf, Max
    Prince, H. Miles
    Januszewicz, E. Henry
    Westerman, David
    Lin, Katherine I.
    Carney, Dennis
    Seymour, John F.
    CANCER, 2006, 106 (11) : 2412 - 2420
  • [3] Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkin's lymphomas.
    Zinzani, PL
    Musuraca, G
    Stefoni, V
    Marchi, E
    Tani, M
    Alinari, L
    Gabriele, A
    Baccarani, M
    BLOOD, 2003, 102 (11) : 285B - 285B
  • [4] Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
    De Angelis, Federico
    Tosti, Maria Elena
    Capria, Saveria
    Russo, Eleonora
    D'Elia, Gianna Maria
    Annechini, Giorgia
    Stefanizzi, Caterina
    Foa, Robin
    Pulsoni, Alessandro
    LEUKEMIA RESEARCH, 2015, 39 (12) : 1382 - 1388
  • [5] Treatment of indolent non-Hodgkin's Lymphomas
    Moreno Nogueira, J. A.
    Casas Fernandez de Tejerina, A.
    Moreno Rey, C.
    REVISTA CLINICA ESPANOLA, 2009, 209 (02): : 82 - 87
  • [6] Low-dose oral fludarabine plus cyclophosphamide as first-line treatment in elderly patients with indolent non-Hodgkin lymphoma
    Fabbri, Alberto
    Lenoci, Mariapia
    Gozzetti, Alessandro
    Chitarrelli, Ida
    Olcese, Francesca
    Raspadori, Donatella
    Gobbi, Marco
    Lauria, Francesco
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 139 (01) : 90 - 93
  • [7] First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma
    Hainsworth, JD
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 9 - 15
  • [8] Salvage chemotherapy using a combination of fludarabine and cyclophosphamide for refractory or relapsing indolent and aggressive non-Hodgkin's lymphomas
    Lossos, IS
    Paltiel, O
    Polliack, A
    LEUKEMIA & LYMPHOMA, 1999, 33 (1-2) : 155 - 160
  • [9] Cladribine for the treatment of indolent non-Hodgkin's lymphomas
    Hoffman, MA
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 40 - 44
  • [10] Oral fludarabine/cyclophosphamide combination in pretreated indolent non-Hodgkin's lymphoma
    Fina, M
    Musuraca, G
    Alinari, L
    Stefoni, V
    Tani, M
    Gabriele, A
    Marchi, E
    Pileri, S
    Baccarani, M
    Zinzani, PL
    ANNALS OF ONCOLOGY, 2005, 16 : 151 - 151
12345